Springleaf has unpledged assets it could offer as collateral in such an exchange, the person said.
Springleaf said in a recent regulatory filing that it is trying to expand in this area.
Springleaf is developing a plan to show investors how it expects to make money in the long run.
And SpringLeaf set out to find investors that could appreciate the unique investment characteristics of its proposed drug-device combination.
If SpringLeaf succeeds, the lives of many patients could be far better off.
With that in mind, Cima and Chiang partnered with Rick Gyory, a drug delivery expert, to found SpringLeaf in September 2007.
And without new mortgages, the consumer-loan volumes alone make it difficult for companies such as Springleaf to keep so many stores open.
Springleaf and OneMain these days make mostly nonreal-estate loans to people who need to fix homes and cars or pay for consumer goods.
Springleaf used to be part of American International Group Inc.
When it was a subsidiary of AIG, American General Finance, as Springleaf used to be called, issued bonds at interest rates of 5% to 7% and made loans at rates that often topped 10%.
In order to get investors interested, SpringLeaf needed to get its hands on a large-molecule drug that had already been through the regulatory gamut so that its novel delivery system would greatly improve that mature drug by giving patients greater convenience and control and thus boosting sales of the combination.
应用推荐